UTMD — Utah Medical Products Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual income statement for Utah Medical Products, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	42.2	49.1	52.3	50.2	40.9
Cost of Revenue
Gross Profit	25.5	30.9	32.2	30	24.1
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	28.5	30.2	32.5	33.4	27.3
Operating Profit	13.7	18.9	19.8	16.8	13.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13.8	19.1	20.7	20.1	16.8
Provision for Income Taxes
Net Income After Taxes	11.1	14.8	16.5	16.6	13.9
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	10.8	14.8	16.5	16.6	13.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10.8	14.8	16.5	16.6	13.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.01	4.05	4.67	4.95	4.46
Dividends per Share
Special Dividends per Share